Tweet
I need a tool to analyze the reference sequence, especially about the repeats in it.
Is MUMmer enough?
Thank you for your help!
Is MUMmer enough?
Thank you for your help!
-
-
If by "analyze" you mean "find" then I would recommend TRF by Gary Benson's lab. If by "analyze" you mean "infer alleles from nextgen data" then the answer is more complicated. -
But it seems that TRF only gives me the tandem repeats.Originally posted by genericforms View Post
I need the information about the sparsed repeats, too.
Thank you!Comment
-
So for the most comprehensive list of repetitive regions I would go for RepeatMasker. Fortunately UCSC hosts RepeatMasker runs so depending on the reference genome you might not even have to run anything.Originally posted by ufwsse View PostComment
-
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment